Duchenne is a particularly debilitating and rapidly progressive form of muscular dystrophy affecting about 1 in every 3,500 male births worldwide.

Dr. Wagers has received significant support from the National Institutes of Health throughout her career, including funding for the most recent mouse study. She credits an NIH “New Innovator” award early in her career as having had a “catalytic effect” on the direction of her work.